Free Preview — Investor scores & financials for CL. Sign up for full buy targets.
Start Free

Is Colgate-Palmolive Company (CL) Undervalued? Valuation & Fair Price

At $86.06, 4 of the 4 frameworks would pass on Colgate-Palmolive Company today — Warren Buffett, Benjamin Graham, Peter Lynch, and Phil Town (Rule #1) rate it Avoid. Each model calculates its own fair value and margin of safety; create a free account to see the exact buy price behind every verdict.

CL

Colgate-Palmolive Company

CL

Consumer Defensive · Household & Personal Products · NYSE

$86.06

P/E 36.3×

CEO

Noel R. Wallace

Sector

Consumer Defensive

Industry

Household & Personal Products

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.

Investor scorecard

How the four investors rate Colgate-Palmolive Company

4 of 4 frameworks urge caution

Warren Buffett
72%Avoid
Benjamin Graham
29%Avoid
Peter Lynch
53%Avoid
Phil Town (Rule #1)
55%Avoid

Investor model analysis

Details locked

At $86.06, 4 of 4 frameworks say Avoid

Business Quality53/100

Intrinsic Value (DCF)

Warren Buffett's valuation model · select an investor above to switch

Intrinsic Value

Locked — upgrade to view

Buy Below

Locked — upgrade to view

Strong Buy

Locked — upgrade to view

Margin of Safety

Locked — upgrade to view

Unlock buy targets with a free account

Get started

Create a free account to see buy targets, full checklists & risk analysis Get started

Insider & congress activity

Are insiders buying CL?

Over recent SEC Form 4 filings, CL insiders bought $0 and sold $32.0M of stock across 6 open-market trades. Insiders sell for many reasons, but they buy for one.

Bought $0Sold $32.0M
Recent open-market insider trades for CL
InsiderActionSharesValueDate
Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSell10,000$920KAug 24, 2026
CAHILL JOHN TdirectorSell4,170$389KAug 6, 2026
Wallace Noel R.Chairman, President & CEOSell161,021$14.9MAug 5, 2026
Wallace Noel R.Chairman, President & CEOSell161,021$14.8MAug 4, 2026
Malcolm GregoryEVP and ControllerSell2,300$203KMay 15, 2026

Members of Congress have also reported 50 trades in CL. See the full insider & congress timeline.

Source: SEC Form 4 filings. Open-market buys & sells only. Not investment advice.

See the interactive insider chart & every trade

Scenario analysis

Bear, base & bull

Three growth assumptions, three fair values — and where today's price lands

What's working

Key strengths

Identified by Buffett framework analysis

Return on Equity

ROE Consistency

Debt Levels

Risk factors & concerns — free account

Unlock

Company financials

5-Year Financials

Income statement highlights — annual, USD

Metric20252024202320222021
Revenue$20.4B
$20.1B
$19.5B
$18.0B
$17.4B
Rev. Growth+1.4%+3.3%+8.3%+3.1%—
Net Income$2.1B$2.9B$2.3B$1.8B$2.2B
Net Margin10.5%14.4%11.8%9.9%12.4%
EPS (Diluted)$2.64$3.53$2.78$2.13$2.56
Free Cash FlowLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to view

Full analysis included

See the complete picture for CL

Exact buy targets, margin of safety, detailed investor checklists, and risk breakdown — all frameworks, all numbers.

Buy & sell targetsFull checklistRisk breakdown

Free: 3 analyses/month · Pay per stock: $4.99 · Pro: $19.99/mo

More Consumer Defensive stocks

Educational Use Only · Not Financial Advice

Analysis, scores, valuations, and buy zones are derived from publicly documented investor frameworks (Buffett, Lynch, Benjamin Graham, Phil Town) for learning purposes only. They are not recommendations from licensed financial advisors. Past performance does not guarantee future results. Prices may be delayed up to 15 minutes. Always conduct your own research before making any investment decisions.